Skip to main content
. 2024 Sep 27;14(10):1032. doi: 10.3390/jpm14101032
EmBase
No. Search Hits
#80 #19 AND #47 AND #78 12,819
#79 #21 AND #47 AND #78
#78 #48 OR #49 OR #50 OR #51 OR #52 OR #53 OR #54 OR #55 OR #56 OR #57 OR #58 OR #59 OR #60 OR #61 OR #62 OR #63 OR #64 OR #65 OR #66 OR #67 OR #68 OR #69 OR #70 OR #71 OR #72 OR #73 OR #74 OR #75 OR #76 OR #77
#77 ‘questionnaire’/exp
#76 ‘interview’/exp
#75 ‘experience’/exp
#74 ‘perception’/exp
#73 ‘health personnel attitude’/exp
#72 ‘attitude’/exp
#71 ‘use of’
#70 ‘survey*’
#69 ‘questionnaire*’
#68 ‘interview*’
#67 ‘focus group*’
#66 ‘facilitator*’
#65 ‘enabler*’
#64 ‘challenge*’
#63 ‘barrier*’
#62 ‘believe’
#61 ‘belief*’
#60 ‘experience*’
#59 ‘value’
#58 ‘perception*’
#57 perceive
#56 adoption
#55 implementation
#54 ‘comprehension’
#53 understand*’
#52 ‘opinion*’
#51 ‘health personnel attitude’
#50 ‘attitude*’
#49 ‘perspective*’
#48 ‘view*’
#47 #22 OR #23 OR #24 OR #25 OR #26 OR #27 OR #28 OR #29 OR #30 OR #31 OR #32 OR #33 OR #34 OR #35 OR #36 OR #37 OR #38 OR #39 OR #40 OR #41 OR #42 OR #43 OR #44 OR #45 OR #46
#46 ‘psychosis’/exp
#45 ‘schizophrenia’/exp
#44 ‘bipolar disorder’/exp
#43 ‘anxiety disorder’/exp
#42 ‘major depression’/exp
#41 ‘mood stabilizer’
#40 ‘mood stabiliser’
#39 ‘antipsychotic*’
#38 ‘antidepressant*’
#37 ‘psychotic’
#36 ‘psychosis’
#35 ‘schizophren*’
#34 ‘bipolar*’
#33 ‘affective*’
#32 ‘anxiety’
#31 ‘depress*’
#30 ‘mood disorder’/exp
#29 ‘mood disorder’
#28 ‘psychiatry’/exp
#27 ‘psychiatr*’
#26 ‘mental disease’/exp
#25 ‘mental health*’
#24 ‘mental disorder’
#23 ‘mental disease’
#22 ‘mental illness’
#21 #19 OR #20
#20 #13 OR #14 OR #15 OR #16 OR #17 OR #18 OR #19
#19 #1 OR #2 OR #3 OR #4 OR #5 OR #6 OR #7 OR #8 OR #9 OR #10 OR #11 OR #12
#18 ‘genetic screening’/exp
#17 ‘genetic information’
#16 ‘genetic variation’
#15 ‘genetic profile’
#14 ‘genetic variant*’
#13 ‘genetic test*’
#12 personalized medicine’/exp
#11 ‘precision prescribing’
#10 ‘precision medicine’
#9 ‘personali*ed prescribing’
#8 ‘personalized medicine’
#7 ‘personalised medicine’
#6 ‘pharmacogenetic testing’/exp
#5 ‘pharmacogen* test*’
#4 ‘pharmacogenetics’/exp
#3 ‘pharmacogenetic*’
#2 ‘pharmacogenomics’/exp
#1 ‘pharmacogenomic*’
Medline
#79 S12 AND S49 AND S77 7400
#78 S21 AND S49 AND S77 16,920
#77 S50 OR S51 OR S52 OR S53 OR S54 OR S55 OR S56 OR S57 OR S58 OR S59 OR S60 OR S61 OR S62 OR S63 OR S64 OR S65 OR S66 OR S67 OR S68 OR S69 OR S70 OR S71 OR S72 OR S73 OR S74 OR S75 OR S76
#76 “use of”
#75 “survey”
#74 (MH “Surveys and Questionnaires”)
#73 “questionnaire”
#72 (MH “Focus Groups”)
#71 “focus group*”
#70 “interview*”
#69 “facilitator*”
#68 “enabler*”
#67 “challenge*”
#66 “barrier*”
#65 “believe”
#64 “belief*”
#63 “experience*”
#62 “value”
#61 “perception*”
#60 (MH “Perception”)
#59 “perceive”
#58 “adoption”
#57 (MH “Implementation Science”)
#56 “implementation”
#55 “understand*”
#54 “opinion*”
#53 (MH “Attitude of Health Personnel”) OR (MH “Attitude”)
#52 “attitude*”
#51 “perspective*”
#50 “view*”
#49 S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 OR S32 OR S33 OR S34 OR S35 OR S36 OR S37 OR S38 OR S39 OR S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47 OR S48
#48 “mood stabiliser*”
#47 (MH “Antipsychotic Agents”)
#46 “antipsychotic*”
#45 (MH “Serotonin and Noradrenaline Reuptake Inhibitors”) OR (MH “Selective Serotonin Reuptake Inhibitors”)
#44 (MH “Antidepressive Agents, Tricyclic”) OR (MH “Antidepressive Agents”)
#43 “antidepressant*”
#42 (MH “Psychotic Disorders”)
#41 (MH “Schizophrenia”) OR (MH “Schizophrenia, Catatonic”) OR (MH “Schizophrenia, Paranoid”) OR (MH “Schizophrenia, Treatment-Resistant”) OR (MH “Schizophrenia Spectrum and Other Psychotic Disorders”)
#40 (MH “Bipolar Disorder”) OR (MH “Bipolar and Related Disorders”)
#39 (MH “Anxiety”) OR (MH “Anxiety Disorders”)
#38 (MH “Depression”) OR (MH “Depressive Disorder, Treatment-Resistant”) OR (MH “Depressive Disorder”) OR (MH “Depressive Disorder, Major”) OR (MH “Depression, Chemical”)
#37 “psychotic*”
#36 “psychosis”
#35 “schizophren*”
#34 “bipolar”
#33 “anxiety”
#32 “depress*”
#31 (MH “Mood Disorders”) OR (MH “Bipolar Disorder”) OR (MH “Affective Disorders, Psychotic”)
#30 “mood disorder”
#29 (MH “Psychiatry”)
#28 “psychiatr*”
#27 (MH “Mental Health”) OR (MH “Mental Health Services”)
#26 (MH “Mental Disorders”)
#25 “mental health*”
#24 “mental disease”
#23 “mental disorder”
#22 “mental illness”
#21 S12 OR S20
#20 S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19
#19 (MH “Pharmacogenomic Variants”) OR (MH “Genetic Variation”) OR (MH “Polymorphism, Genetic”)
#18 (MH “Genetic Testing”)
#17 “genetic information”
#16 “genetic screening”
#15 “genetic variation”
#14 “genetic variant*”
#13 “genetic test*”
#12 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11
#11 (MH “Precision Medicine”)
#10 “precision prescribing”
#9 “personalized prescribing”
#8 “personalised prescribing”
#7 “precision medicine”
#6 “personalised medicine”
#5 “personalized medicine”
#4 (MH “Pharmacogenetics”) OR (MH “Pharmacogenomic Testing”) OR (MH “Pharmacogenomic Variants”)
#3 “pharmacogenetic test*”
#2 “pharmacogenetic*”
#1 “pharmacogenomic*”
PsycInfo
No. Term Hits
S73 S15 AND S48 AND S71 2680
S72 S22 AND S48 AND S71
S71 S49 OR S50 OR S51 OR S52 OR S53 OR S54 OR S55 OR S56 OR S57 OR S58 OR S59 OR S60 OR S61 OR S62 OR S63 OR S64 OR S65 OR S66 OR S67 OR S68 OR S69 OR S70
S70 (((((DE “Attitudes”) OR (DE “Perception”)) AND (DE “Semi-Structured Interview” OR DE “Focus Group Interview” OR DE “Interviews”)) OR (DE “Focus Group”)) OR (DE “Surveys”)) OR (DE “Questionnaires”)
S69 “use of”
S68 survey*
S67 questionnaire
S66 “focus group*”
S65 interview*
S64 facilitator*
S63 enabler*
S62 challenge*
S61 barrier*
S60 believe
S59 belief*
S58 experience*
S57 value
S56 perceive
S55 adoption
S54 implementation
S53 understand*
S52 opinion*
S51 attitude*
S50 perspective*
S49 view*
S48 S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 OR S32 OR S33 OR S34 OR S35 OR S36 OR S37 OR S38 OR S39 OR S40 OR S41 OR S42 OR S43 OR S44 OR S45 OR S46 OR S47
S47 “mood stabili*er”
S46 DE “Affective Disorders”
S45 DE “Tricyclic Antidepressant Drugs” OR DE “Antidepressant Drugs” OR DE “Serotonin Norepinephrine Reuptake Inhibitors”
S44 DE “Neuroleptic Drugs” OR DE “Neuroleptic Malignant Syndrome” OR DE “Psychotropic Drugs”
S43 antidepressant*
S42 antipsychotic*
S41 DE “Psychosis”
S40 DE “Schizophrenia” OR DE “Schizophrenia (Disorganized Type)” OR DE “Childhood Onset Schizophrenia” OR DE “Undifferentiated Schizophrenia” OR DE “Process Schizophrenia” OR DE “Paranoid Schizophrenia” OR DE “Catatonic Schizophrenia” OR DE “Acute Schizophrenia” OR DE “Schizophreniform Disorder” OR DE “Schizoaffective Disorder”
S39 DE “Bipolar Disorder” OR DE “Bipolar I Disorder” OR DE “Bipolar II Disorder” OR DE “Mood Stabilizers”
S38 DE “Anxiety” OR DE “Anxiety Disorders” OR DE “Generalized Anxiety Disorder”
S37 DE “Major Depression” OR DE “Depression (Emotion)” OR DE “Postpartum Depression” OR DE “Reactive Depression” OR DE “Treatment Resistant Depression” OR DE “Bipolar Disorder” OR DE “Late Life Depression” OR DE “Recurrent Depression” OR DE “Endogenous Depression” OR DE “Atypical Depression” OR DE “Long-term Depression (Neuronal)” OR DE “Seasonal Affective Disorder”
S36 psychotic
S35 psychosis
S34 schizophren*
S33 bipolar
S32 anxiety
S31 depressi*
S30 DE “Mental Health” OR DE “Mental Health Services”
S29 DE “Psychiatry”
S28 “mood disorder”
S27 psychiatr*
S26 “mental health*”
S25 “mental disease”
S24 “mental disorder”
S23 “mental illness”
S22 S15 OR S21
S21 S16 OR S17 OR S18 OR S19 OR S20
S20 DE “Genetic Testing”
S19 “genetic information”
S18 “genetic screen*”
S17 “genetic varia*”
S16 “genetic test*”
S15 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 OR S13 OR S14
S14 DE “Precision Medicine”
S13 “personalized prescribing”
S12 “personalized medicine”
S11 “precision prescribing”
S10 “precision medicine”
S9 “personalised prescribing”
S8 “personalised medicine”
S7 DE “Pharmacogenetics”
S6 “pharmacogenomic testing”
S5 “pharmacogenetic testing”
S4 pharmacogenetic*
S3 pharmacogenetics
S2 pharmacogenomic*
S1 Pharmacogenomics
Scopus
No. Term Hits
S73 ((TITLE-ABS-KEY (“view*”)) OR (TITLE-ABS-KEY (“perspective*”)) OR (TITLE-ABS-KEY (“attitude*”)) OR (TITLE-ABS-KEY (“opinion*”)) OR (TITLE-ABS-KEY (“understand*”)) OR (TITLE-ABS-KEY (“implementation”)) OR (TITLE-ABS-KEY (“adoption”)) OR (TITLE-ABS-KEY (“perceive”)) OR (TITLE-ABS-KEY (“value”)) OR (TITLE-ABS-KEY (“experience*”)) OR (TITLE-ABS-KEY (“belief*”)) OR (TITLE-ABS-KEY (“believe”)) OR (TITLE-ABS-KEY (“barrier*”)) OR (TITLE-ABS-KEY (“challenge*”)) OR (TITLE-ABS-KEY (“enabler*”)) OR (TITLE-ABS-KEY (“facilitator*”)) OR (TITLE-ABS-KEY (“interview*”)) OR (TITLE-ABS-KEY (“focus group*”)) OR (TITLE-ABS-KEY (“questionnaire”)) OR (TITLE-ABS-KEY (“survey*”))) AND (((TITLE-ABS-KEY (“precision prescribing”)) OR (TITLE-ABS-KEY (“precision medicine”)) OR (TITLE-ABS-KEY (“personalized prescribing”)) OR (TITLE-ABS-KEY (“personalised prescribing”)) OR (TITLE-ABS-KEY (“personalized medicine”)) OR (TITLE-ABS-KEY (“personalised medicine”)) OR (TITLE-ABS-KEY (“pharmacogenomic testing”)) OR (TITLE-ABS-KEY (“pharmacogenetic testing”)) OR (TITLE-ABS-KEY (pharmacogenetic*)) OR (TITLE-ABS-KEY (pharmacogenetics)) OR (TITLE-ABS-KEY (pharmacogenomic*)) OR (TITLE-ABS-KEY (pharmacogenomics))) AND ((TITLE-ABS-KEY (“mental illness”)) OR (TITLE-ABS-KEY (“mental disorder”)) OR (TITLE-ABS-KEY (“mental disease”)) OR (TITLE-ABS-KEY (“mental health”)) OR (TITLE-ABS-KEY (“psychiatr*”)) OR (TITLE-ABS-KEY (“mood disorder”)) OR (TITLE-ABS-KEY (“depressi*”)) OR (TITLE-ABS-KEY (“anxiety”)) OR (TITLE-ABS-KEY (“bipolar”)) OR (TITLE-ABS-KEY (“schizophren*”)) OR (TITLE-ABS-KEY (“psychosis”)) OR (TITLE-ABS-KEY (“psychotic”)) OR (TITLE-ABS-KEY (“affective”)) OR (TITLE-ABS-KEY (“antipsychotic*”)) OR (TITLE-ABS-KEY (“antidepressant*”)) OR (TITLE-ABS-KEY (“mood stabili*er*”)))) 5246
Description: in the table is the full searching strategy used during in the review.